UvA-DARE Age-Dependent Effects of Methylphenidate on the Human Dopaminergic System in Young vs Adult Patients With Attention-Deficit/Hyperactivity Disorder: A Randomized Clincal Trial

the determine whether the effects of methylphenidate on the dopaminergic system are modified by and to test the hypothesis that methylphenidate treatment of young but not adult patients with ADHD induces lasting effects on the cerebral blood flow response to dopamine challenge, a noninvasive probe for dopamine function.

[1]  M. Abdel-Hamid,et al.  Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. , 2015, JAMA psychiatry.

[2]  M. Caan,et al.  Dopaminergic System Dysfunction in Recreational Dexamphetamine Users , 2015, Neuropsychopharmacology.

[3]  Florence T. Bourgeois,et al.  Premarket Safety and Efficacy Studies for ADHD Medications in Children , 2014, PloS one.

[4]  Susan L. Andersen,et al.  Juvenile methylphenidate reduces prefrontal cortex plasticity via D3 receptor and BDNF in adulthood , 2014, Front. Synaptic Neurosci..

[5]  K. Humphreys,et al.  Stimulant medication and substance use outcomes: a meta-analysis. , 2013, JAMA psychiatry.

[6]  David Coghill,et al.  Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. , 2013, The American journal of psychiatry.

[7]  Andrea L. Howard,et al.  Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. , 2013, Journal of the American Academy of Child and Adolescent Psychiatry.

[8]  B. Waterhouse,et al.  Distinct Age-Dependent Effects of Methylphenidate on Developing and Adult Prefrontal Neurons , 2012, Biological Psychiatry.

[9]  Bruce G. Jenkins,et al.  Pharmacologic magnetic resonance imaging (phMRI): Imaging drug action in the brain , 2012, NeuroImage.

[10]  L. Hechtman,et al.  A randomized controlled trial of CBT therapy for adults with ADHD with and without medication , 2012, BMC Psychiatry.

[11]  J. Swanson,et al.  Methylphenidate-Elicited Dopamine Increases in Ventral Striatum Are Associated with Long-Term Symptom Improvement in Adults with Attention Deficit Hyperactivity Disorder , 2012, The Journal of Neuroscience.

[12]  J. Buitelaar,et al.  To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended? , 2011, European Neuropsychopharmacology.

[13]  G. Gudjonsson,et al.  Cognitive behaviour therapy in medication-treated adults with ADHD and persistent Symptoms: A randomized controlled trial , 2011, BMC psychiatry.

[14]  Todd E. Elder,et al.  The importance of relative standards in ADHD diagnoses: evidence based on exact birth dates. , 2010, Journal of health economics.

[15]  Susan Sprich,et al.  Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. , 2010, JAMA.

[16]  J. Swanson,et al.  The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. , 2009, Journal of the American Academy of Child and Adolescent Psychiatry.

[17]  David C. Alsop,et al.  Increased cerebral perfusion in adult attention deficit hyperactivity disorder is normalised by stimulant treatment: A non-invasive MRI pilot study , 2008, NeuroImage.

[18]  D. Seals,et al.  Decreased maximal heart rate with aging is related to reduced {beta}-adrenergic responsiveness but is largely explained by a reduction in intrinsic heart rate. , 2008, Journal of applied physiology.

[19]  S. Andersen,et al.  Juvenile methylphenidate modulates reward‐related behaviors and cerebral blood flow by decreasing cortical D3 receptors , 2008, The European journal of neuroscience.

[20]  K. Braun,et al.  Early stress and chronic methylphenidate cross‐sensitize dopaminergic responses in the adolescent medial prefrontal cortex and nucleus accumbens , 2007, Journal of neurochemistry.

[21]  D. Leblanc-Duchin,et al.  Chronic oral methylphenidate administration to periadolescent rats yields prolonged impairment of memory for objects , 2007, Neurobiology of Learning and Memory.

[22]  Ji-Kyung Choi,et al.  Brain hemodynamic changes mediated by dopamine receptors: Role of the cerebral microvasculature in dopamine-mediated neurovascular coupling , 2006, NeuroImage.

[23]  J. Biederman,et al.  Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. , 2006, Clinical therapeutics.

[24]  J. S. Lee,et al.  Regional cerebral blood flow in children with attention deficit hyperactivity disorder: Comparison before and after methylphenidate treatment , 2005, Human brain mapping.

[25]  B. Jenkins,et al.  Mapping Dopamine Function in Primates Using Pharmacologic Magnetic Resonance Imaging , 2004, The Journal of Neuroscience.

[26]  S. Andersen,et al.  Altering the course of neurodevelopment: a framework for understanding the enduring effects of psychotropic drugs , 2004, International Journal of Developmental Neuroscience.

[27]  S. Mague,et al.  Enduring behavioral effects of early exposure to methylphenidate in rats , 2003, Biological Psychiatry.

[28]  T. Insel,et al.  What are the long-term effects of methylphenidate treatment? , 2003, Biological Psychiatry.

[29]  J. Swanson,et al.  Serum and brain concentrations of methylphenidate: implications for use and abuse , 2003, Neuroscience & Biobehavioral Reviews.

[30]  L. Rohde,et al.  The acute effect of methylphenidate on cerebral blood flow in boys with attention-deficit/hyperactivity disorder , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[31]  J. Monterosso,et al.  Effects of methylphenidate discontinuation on cerebral blood flow in prepubescent boys with attention deficit hyperactivity disorder. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  Scott T. Grafton,et al.  A Positron Emission Tomography Study Of Methylphenidate in Adults with ADHD: Alterations in Resting Blood Flow and Predicting Treatment Response , 2002, Neuropsychopharmacology.

[33]  Alan C. Evans,et al.  Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. , 2002, JAMA.

[34]  Alan C. Evans,et al.  Brain development during childhood and adolescence: a longitudinal MRI study , 1999, Nature Neuroscience.

[35]  B R Rosen,et al.  Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: Correlation with PET, microdialysis, and behavioral data , 1997, Magnetic resonance in medicine.

[36]  H. Geurts,et al.  The effects of Psychotropic drugs On the Developing brain (ePOD) study: methods and design , 2016 .

[37]  M. Frydenberg,et al.  ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study. , 2014, Addictive behaviors.

[38]  A. Schrantee,et al.  UvA-DARE ( Digital Academic Repository ) Pharmacological MRI in the assessment of monoaminergic function , 2013 .

[39]  Alan C. Evans,et al.  Psychostimulant treatment and the developing cortex in attention deficit hyperactivity disorder. , 2009, The American journal of psychiatry.

[40]  E. Rüther,et al.  Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters. , 2001, Journal of child and adolescent psychopharmacology.